QC workflows are expanding—your data system must keep up.
Quality control (QC) labs are under increasing pressure to stay efficient, maintain compliance, and keep batch release on schedule. As drug modalities grow more complex, demonstrating FDA and EMA process control requires greater traceability and consistency across every result—elevating data systems from a supporting role to a core driver of workflow consistency, data integrity, and confident batch release.
Agilent OpenLab CDS delivers a single analytical data system that unifies and standardizes QC workflows today, while scaling naturally to support advanced analytical needs as the lab evolves.
The reality facing QC labs today
0%
of oncology trial starts now involve novel modalities1
0%
of biopharma executives say QC labs still run on disconnected systems with limited automation2
0%
of labs operate multiple generations of instruments and software3
As the role of the data system in QC has grown, not every system has kept pace. OpenLab CDS has.
OpenLab CDS: A single data system for modern QC labs
Built on the same rigor and reliability expected from Agilent instrumentation, OpenLab CDS has long been trusted in QC environments that analyze small molecules. As QC workflows expanded, OpenLab CDS evolved from a chromatography data system into a unified analytical data system, bringing chromatography and mass spectrometry together in a single, consistent environment.
That evolution makes OpenLab CDS a natural fit for large molecule and advanced mass spectrometry workflows. Rather than introducing a separate system for high-resolution mass spectrometry (HRMS), OpenLab CDS extends the same harmonized, inspection ready environment QC labs already rely on, so new workflows can be adopted without changing how data is governed, reviewed, or supported.
0 of 20
top worldwide pharma companies rely on OpenLab CDS 3,4
What this evolution unlocks for QC labs
HRMS workflows using TOF and Q-TOF instruments run alongside existing workflows in one integrated process, connecting familiar software such as Agilent Mass Hunter BioConfirm and Agilent MassHunter Qualitative Analysis—without adding new systems or retraining.
Built on a client/server architecture, OpenLab CDS supports growth without disruption—enabling advanced MS workflows to scale across labs and sites.
As regulatory expectations for QC lot release become more stringent, such as USP <1060>, OpenLab CDS supports harmonized workflows that maintain data integrity, reduce variability, and help labs defend results with confidence.
As data volumes grow, OpenLab CDS coupled with OpenLab Data Management, keeps data organized, secure, and protected from loss, supporting audit readiness.
Supports emerging QC methods, such as MAM, with reliable method transfer and alignment with regulatory guidelines.
"Managers and analysts are more focused on science and quality throughput,
as analyses that once took days or hours are now completed in minutes.”
– Jayakumar A V, Executive Vice President, Ajanta Pharma
The OpenLab CDS advantage
Advanced MS without disruption
Advanced MS without disruption
-
Expand into new analytical approaches while keeping existing QC running smoothly.
Scalable operations
Scalable operations
-
Support growing QC workflows and data volumes without adding new data systems.
Compliance you can rely on
Compliance you can rely on
-
Maintain defensible results as regulatory expectations increase.
On-time batch release
On-time batch release
-
Keep operations reliable and on schedule as demands grow.
Modern user interface
Modern user interface
-
Simplify daily work with an intuitive, easy-to-use interface.
Ready for what’s next?
OpenLab CDS extends the same trusted QC data system to support growing workflows and advanced analytical needs, without disrupting how labs work or manage compliance. Talk to an expert to see how OpenLab CDS can support your next phase of QC.
Contact usRelated resources
1 IQVIA Institute for Human Data Science. Global Trends in R&D 2025: Progress in Recapturing Momentum in Biopharma Innovation; IQVIA: 2025.
2 Deloitte Insights. Pharma’s QC Lab of the Future: Boosting Speed, Compliance, and Quality. Deloitte, Apr 1, 2025. Accessed May 19, 2026.
3 Agilent Technologies, internal data, unpublished.
4 Dunleavy, K. The Top 20 Pharma Companies by 2025 Revenue. Fierce Pharma, Apr 20, 2026. Accessed May 19, 2026.